Pia M. Lind

Uppsala, C, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 92 publications

Metabolome-wide association study identifies metabolites associated with human exposure to perfluoroalkyl substances.

Metabolome-wide association study identifies metabolites associated with human exposure to perfluoroalkyl substances.

Journal: Journal of exposure science & environmental epidemiology

Published: January 14, 2026

An exploratory study of environmental and nutritional determinants of early-stage clonal hematopoiesis in the elderly.

An exploratory study of environmental and nutritional determinants of early-stage clonal hematopoiesis in the elderly.

Journal: Environment international

Published: January 05, 2026

Longitudinal and cross-sectional analysis of perfluoroalkyl substances and kidney function.

Longitudinal and cross-sectional analysis of perfluoroalkyl substances and kidney function.

Journal: Journal of exposure science & environmental epidemiology

Published: November 06, 2024

Rethinking cholesterol: the role of lipophilic pollutants.

Rethinking cholesterol: the role of lipophilic pollutants.

Journal: European journal of preventive cardiology

Published: October 07, 2024

Environmental contaminants, sex hormones and SHBG in an elderly population.

Environmental contaminants, sex hormones and SHBG in an elderly population.

Journal: Environmental research

Published: June 29, 2024

Developmental low-dose bisphenol A exposure leads to extensive transcriptome female masculinization and male feminization later in life.

Developmental low-dose bisphenol A exposure leads to extensive transcriptome female masculinization and male feminization later in life.

Journal: Communications medicine

Published: June 14, 2023

Plasma levels of per- and polyfluoroalkyl substances (PFAS) and cardiovascular disease - Results from two independent population-based cohorts and a meta-analysis.

Plasma levels of per- and polyfluoroalkyl substances (PFAS) and cardiovascular disease - Results from two independent population-based cohorts and a meta-analysis.

Journal: Environment international

Published: April 11, 2023

Associations of perfluoroalkyl substances (PFAS) with lipid and lipoprotein profiles.

Associations of perfluoroalkyl substances (PFAS) with lipid and lipoprotein profiles.

Journal: Journal of exposure science & environmental epidemiology

Published: November 11, 2022

Associations between per- and polyfluoroalkyl substances (PFAS) and diabetes in two population-based cohort studies from Sweden.

Associations between per- and polyfluoroalkyl substances (PFAS) and diabetes in two population-based cohort studies from Sweden.

Journal: Journal of exposure science & environmental epidemiology

Published: October 20, 2022

Plasma levels of per- and polyfluoroalkyl substances (PFAS) are associated with altered levels of proteins previously linked to inflammation, metabolism and cardiovascular disease.

Plasma levels of per- and polyfluoroalkyl substances (PFAS) are associated with altered levels of proteins previously linked to inflammation, metabolism and cardiovascular disease.

Journal: Environment international

Published: September 16, 2022

Corrigendum to "Obesity II: Establishing causal links between chemical exposures and obesity" [Biochem. Pharmacol. 199 (2022) 115015].

Corrigendum to "Obesity II: Establishing causal links between chemical exposures and obesity" [Biochem. Pharmacol. 199 (2022) 115015].

Journal: Biochemical pharmacology

Published: June 17, 2022

Changes in plasma levels of per- and polyfluoroalkyl substances (PFAS) are associated with changes in plasma lipids - A longitudinal study over 10 years.

Changes in plasma levels of per- and polyfluoroalkyl substances (PFAS) are associated with changes in plasma lipids - A longitudinal study over 10 years.

Journal: Environmental research

Published: November 11, 2021

Showing 1-12 of 92

Last Updated: 09/26/2026